Literature DB >> 18565996

The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils.

Alexandra Belus1, Nicoletta Piroddi, Beatrice Scellini, Chiara Tesi, Giulia D'Amati, Francesca Girolami, Magdi Yacoub, Franco Cecchi, Iacopo Olivotto, Corrado Poggesi.   

Abstract

The R403Q mutation in beta-myosin heavy chain was the first mutation to be identified as responsible for familial hypertrophic cardiomyopathy (FHC). In spite of extensive work on the functional sequelae of this mutation, the mechanism by which the mutant protein causes the disease has not been definitely identified. Here we directly compare contraction and relaxation mechanics of single myofibrils from left ventricular samples of one patient carrying the R403Q mutation to those from a healthy control heart. Tension generation and relaxation following sudden increase and decrease in [Ca(2+)] were much faster in the R403Q myofibrils with relaxation rates being the most affected parameters. The results show that the R403Q mutation leads to an apparent gain of protein function but a greater energetic cost of tension generation. Increased energy cost of tension generation may be central to the FHC disease process, help explain some unresolved clinical observations, and carry significant therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18565996      PMCID: PMC2538824          DOI: 10.1113/jphysiol.2008.155952

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  22 in total

Review 1.  Regulation of contraction in striated muscle.

Authors:  A M Gordon; E Homsher; M Regnier
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

2.  Relaxation kinetics following sudden Ca(2+) reduction in single myofibrils from skeletal muscle.

Authors:  Chiara Tesi; Nicoletta Piroddi; Francesco Colomo; Corrado Poggesi
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

3.  Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome.

Authors:  M Sata; M Ikebe
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

4.  A transgenic rabbit model for human hypertrophic cardiomyopathy.

Authors:  A J Marian; Y Wu; D S Lim; M McCluggage; K Youker; Q T Yu; R Brugada; F DeMayo; M Quinones; R Roberts
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 5.  Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.

Authors:  Houman Ashrafian; Charles Redwood; Edward Blair; Hugh Watkins
Journal:  Trends Genet       Date:  2003-05       Impact factor: 11.639

6.  Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy.

Authors:  M J Tyska; E Hayes; M Giewat; C E Seidman; J G Seidman; D M Warshaw
Journal:  Circ Res       Date:  2000-04-14       Impact factor: 17.367

Review 7.  Functional consequences of mutations in the myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy.

Authors:  Susan Lowey
Journal:  Trends Cardiovasc Med       Date:  2002-11       Impact factor: 6.677

8.  Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy.

Authors:  Carolyn Y Ho; Nancy K Sweitzer; Barbara McDonough; Barry J Maron; Susan A Casey; J G Seidman; Christine E Seidman; Scott D Solomon
Journal:  Circulation       Date:  2002-06-25       Impact factor: 29.690

9.  Estimation of regional left ventricular wall stresses in intact canine hearts.

Authors:  A DeAnda; M Komeda; M R Moon; G R Green; A F Bolger; S D Nikolic; G T Daughters; D C Miller
Journal:  Am J Physiol       Date:  1998-11

10.  A mouse model of familial hypertrophic cardiomyopathy.

Authors:  A A Geisterfer-Lowrance; M Christe; D A Conner; J S Ingwall; F J Schoen; C E Seidman; J G Seidman
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

View more
  59 in total

1.  Force relaxation and thin filament protein phosphorylation during acute myocardial ischemia.

Authors:  Young Soo Han; Ozgur Ogut
Journal:  Cytoskeleton (Hoboken)       Date:  2010-11-02

Review 2.  Mechanical and energetic consequences of HCM-causing mutations.

Authors:  Cecilia Ferrantini; Alexandra Belus; Nicoletta Piroddi; Beatrice Scellini; Chiara Tesi; Corrado Poggesi
Journal:  J Cardiovasc Transl Res       Date:  2009-10-09       Impact factor: 4.132

Review 3.  The genetic basis of hypertrophic cardiomyopathy in cats and humans.

Authors:  Mark D Kittleson; Kathryn M Meurs; Samantha P Harris
Journal:  J Vet Cardiol       Date:  2015-12       Impact factor: 1.701

4.  Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy.

Authors:  Alexey V Dvornikov; Mingmin Wang; Jingchun Yang; Ping Zhu; Tai Le; Xueying Lin; Hung Cao; Xiaolei Xu
Journal:  J Mol Cell Cardiol       Date:  2019-06-20       Impact factor: 5.000

Review 5.  Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis.

Authors:  Iacopo Olivotto; Franco Cecchi; Corrado Poggesi; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2009-04       Impact factor: 32.419

Review 6.  Phenotyping cardiomyopathy in adult zebrafish.

Authors:  Alexey V Dvornikov; Pieter P de Tombe; Xiaolei Xu
Journal:  Prog Biophys Mol Biol       Date:  2018-05-30       Impact factor: 3.667

7.  Site-specific acetyl-mimetic modification of cardiac troponin I modulates myofilament relaxation and calcium sensitivity.

Authors:  Ying H Lin; William Schmidt; Kristofer S Fritz; Mark Y Jeong; Anthony Cammarato; D Brian Foster; Brandon J Biesiadecki; Timothy A McKinsey; Kathleen C Woulfe
Journal:  J Mol Cell Cardiol       Date:  2020-01-22       Impact factor: 5.000

8.  Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin's HCM mutations.

Authors:  Fan Bai; Adam Weis; Aya K Takeda; P Bryant Chase; Masataka Kawai
Journal:  Biophys J       Date:  2011-02-16       Impact factor: 4.033

9.  Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice.

Authors:  Camille L Birch; Samantha M Behunin; Marissa A Lopez-Pier; Christiane Danilo; Yulia Lipovka; Chandra Saripalli; Henk Granzier; John P Konhilas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

Review 10.  From genotype to phenotype: a longitudinal study of a patient with hypertrophic cardiomyopathy due to a mutation in the MYBPC3 gene.

Authors:  Adam Jacques; Anita C Hoskins; Jonathan C Kentish; Steven B Marston
Journal:  J Muscle Res Cell Motil       Date:  2009-02-14       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.